Roth Capital Estimates OTCMKTS:GTBIF Q4 Earnings

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Research analysts at Roth Capital issued their Q4 2024 earnings per share (EPS) estimates for Green Thumb Industries in a research report issued on Sunday, November 10th. Roth Capital analyst W. Kirk anticipates that the company will earn $0.07 per share for the quarter. Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries’ FY2024 earnings at $0.32 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.08 EPS and FY2025 earnings at $0.30 EPS.

A number of other analysts also recently weighed in on GTBIF. Craig Hallum raised shares of Green Thumb Industries to a “strong-buy” rating in a report on Monday, September 16th. Ventum Cap Mkts upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Three equities research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Strong Buy” and an average target price of $16.50.

Green Thumb Industries Stock Up 8.4 %

GTBIF opened at $9.70 on Wednesday. Green Thumb Industries has a twelve month low of $7.50 and a twelve month high of $16.33. The stock has a market capitalization of $2.05 billion, a price-to-earnings ratio of 35.93 and a beta of 1.40. The company has a 50-day simple moving average of $10.24 and a 200 day simple moving average of $11.08.

Green Thumb Industries (OTCMKTS:GTBIF) last released its earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. The company had revenue of $286.87 million for the quarter, compared to analyst estimates of $283.96 million.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.